Fund Overview of Kotak Healthcare Fund Regular - Growth
-
₹485.3 CrAUM
-
₹13.60NAV
-
2.40%Expense Ratio
-
EquityFund Category
Returns of Kotak Healthcare Fund Regular - Growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 1.22% | NA | 6.12% |
| 6 Months | 12.09% | NA | 12.92% |
| 1 Year | -1.50% | -1.50% | 6.04% |
Asset Allocation
equities
98.71%other assets or cash equivalents
1.29%Kotak Healthcare Fund Regular - Growth is one Equity mutual fund offered by Kotak Mahindra Mutual Fund. Launched on 11 Dec 2023, the fund aims Long term capital growth. Investment in portfolio of predominantly equity & equity related securities of companies engaged in Pharma, Healthcare & allied sectors. It manages assets worth ₹485.3 crore as on Thu Jul 31, 2025. , with a 52-week NAV range between ₹11.79 and ₹14.42. The expense ratio stands at 2.4%. Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager EducationAbout Kotak Healthcare Fund Regular - Growth
The portfolio allocation consists of 98.71% in equities, 1.29% in other assets or cash equivalents. Managed by Dhananjay Tikariha, it has delivered a return of -1.50% in the last year, a total return since inception of 18.33%.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | 0.21% | 0.48% | 9.03% | 28.99% | 21.62% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | 0.12% | 0.25% | 8.10% | 27.87% | 20.55% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -0.03% | -1.35% | 5.10% | 23.18% | 17.50% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -0.13% | -1.67% | 3.76% | 21.53% | 15.83% |
More funds from Kotak Mahindra Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Kotak Healthcare Fund Direct - Growth
|
₹485 | -0.88% | -0.06% | 4.19% | 4.03% | - |
|
Kotak Healthcare Fund Direct - Idcw
|
₹485 | -0.88% | -0.06% | 4.19% | 4.03% | - |
|
Kotak Healthcare Fund Regular - Idcw
|
₹485 | -1.02% | -0.47% | 3.34% | 2.36% | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹40.45 | 27.87% | 20.55% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹43.71 | 28.99% | 21.62% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.21 | 21.53% | 15.83% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹152.37 | 22.80% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.28 | 22.97% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 14.07% | ₹68.27 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.36% | ₹64.25 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.36% | ₹64.25 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.05% | ₹60.58 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.05% | ₹60.58 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.83% | ₹38.00 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.75% | ₹37.30 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.75% | ₹37.30 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.33% | ₹34.00 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.33% | ₹34.00 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 5.87% | ₹28.49 Cr |
| Repo | Unspecified | 5.85% | ₹28.40 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 5.93% | ₹27.53 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 5.93% | ₹27.53 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 5.63% | ₹27.09 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 5.63% | ₹27.09 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.60% | ₹26.95 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.60% | ₹26.95 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.44% | ₹26.38 Cr |
| Cipla Ltd | Healthcare | 5.51% | ₹25.56 Cr |
| Cipla Ltd | Healthcare | 5.51% | ₹25.56 Cr |
| Cipla Ltd | Healthcare | 4.81% | ₹23.32 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.90% | ₹22.76 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.90% | ₹22.76 Cr |
| Cipla Ltd | Healthcare | 4.68% | ₹22.52 Cr |
| Cipla Ltd | Healthcare | 4.68% | ₹22.52 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.25% | ₹20.46 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.25% | ₹20.46 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.23% | ₹20.35 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.23% | ₹20.35 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.09% | ₹19.87 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.23% | ₹19.63 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.23% | ₹19.63 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.18% | ₹19.40 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.18% | ₹19.40 Cr |
| Lupin Ltd | Healthcare | 3.88% | ₹18.65 Cr |
| Lupin Ltd | Healthcare | 3.88% | ₹18.65 Cr |
| Lupin Ltd | Healthcare | 3.91% | ₹18.16 Cr |
| Lupin Ltd | Healthcare | 3.91% | ₹18.16 Cr |
| Jubilant Pharmova Ltd | Healthcare | 3.44% | ₹16.72 Cr |
| Ami Organics Ltd | Healthcare | 3.23% | ₹15.55 Cr |
| Ami Organics Ltd | Healthcare | 3.23% | ₹15.55 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.18% | ₹15.43 Cr |
| Jubilant Pharmova Ltd | Healthcare | 3.20% | ₹15.41 Cr |
| Jubilant Pharmova Ltd | Healthcare | 3.20% | ₹15.41 Cr |
| Jubilant Pharmova Ltd | Healthcare | 3.26% | ₹15.11 Cr |
| Jubilant Pharmova Ltd | Healthcare | 3.26% | ₹15.11 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.03% | ₹14.58 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.03% | ₹14.58 Cr |
| Gland Pharma Ltd | Healthcare | 2.98% | ₹14.45 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.00% | ₹14.42 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.00% | ₹14.42 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.02% | ₹14.00 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.02% | ₹14.00 Cr |
| Gland Pharma Ltd | Healthcare | 3.00% | ₹13.94 Cr |
| Gland Pharma Ltd | Healthcare | 3.00% | ₹13.94 Cr |
| Lupin Ltd | Healthcare | 2.86% | ₹13.89 Cr |
| Gland Pharma Ltd | Healthcare | 2.81% | ₹13.50 Cr |
| Gland Pharma Ltd | Healthcare | 2.81% | ₹13.50 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.90% | ₹13.48 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.90% | ₹13.48 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.77% | ₹13.31 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.77% | ₹13.31 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.68% | ₹13.01 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.79% | ₹12.94 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.79% | ₹12.94 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.62% | ₹12.70 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.64% | ₹12.24 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.64% | ₹12.24 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.62% | ₹12.18 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.62% | ₹12.18 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.51% | ₹12.16 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.52% | ₹12.11 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.52% | ₹12.11 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.51% | ₹12.07 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.51% | ₹12.07 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.49% | ₹11.98 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.49% | ₹11.98 Cr |
| Ami Organics Ltd | Healthcare | 2.46% | ₹11.95 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.57% | ₹11.94 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.57% | ₹11.94 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.48% | ₹11.92 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.48% | ₹11.92 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.45% | ₹11.90 Cr |
| Repo | Unspecified | 2.56% | ₹11.90 Cr |
| Repo | Unspecified | 2.56% | ₹11.90 Cr |
| Ami Organics Ltd | Healthcare | 2.56% | ₹11.86 Cr |
| Ami Organics Ltd | Healthcare | 2.56% | ₹11.86 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.37% | ₹11.51 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.39% | ₹11.50 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.39% | ₹11.50 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.32% | ₹11.27 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.40% | ₹11.13 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.40% | ₹11.13 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.31% | ₹11.09 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.31% | ₹11.09 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.36% | ₹10.95 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.36% | ₹10.95 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.23% | ₹10.83 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.33% | ₹10.83 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.33% | ₹10.83 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.24% | ₹10.78 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.24% | ₹10.78 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.23% | ₹10.33 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.23% | ₹10.33 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.12% | ₹10.27 Cr |
| Marksans Pharma Ltd | Healthcare | 2.06% | ₹10.01 Cr |
| Laxmi Dental Ltd. | Healthcare | 2.10% | ₹9.76 Cr |
| Laxmi Dental Ltd. | Healthcare | 2.10% | ₹9.76 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.00% | ₹9.70 Cr |
| Laxmi Dental Ltd. | Healthcare | 1.96% | ₹9.43 Cr |
| Laxmi Dental Ltd. | Healthcare | 1.96% | ₹9.43 Cr |
| Marksans Pharma Ltd | Healthcare | 1.89% | ₹9.10 Cr |
| Marksans Pharma Ltd | Healthcare | 1.89% | ₹9.10 Cr |
| Laxmi Dental Ltd. | Healthcare | 1.83% | ₹8.86 Cr |
| Krsnaa Diagnostics Ltd | Healthcare | 1.78% | ₹8.61 Cr |
| Innova Captab Ltd. | Healthcare | 1.72% | ₹8.37 Cr |
| Marksans Pharma Ltd | Healthcare | 1.78% | ₹8.25 Cr |
| Marksans Pharma Ltd | Healthcare | 1.78% | ₹8.25 Cr |
| Innova Captab Ltd. | Healthcare | 1.75% | ₹8.10 Cr |
| Innova Captab Ltd. | Healthcare | 1.75% | ₹8.10 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.69% | ₹7.86 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.69% | ₹7.86 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.62% | ₹7.80 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.62% | ₹7.80 Cr |
| Innova Captab Ltd. | Healthcare | 1.62% | ₹7.78 Cr |
| Innova Captab Ltd. | Healthcare | 1.62% | ₹7.78 Cr |
| Krsnaa Diagnostics Ltd | Healthcare | 1.61% | ₹7.77 Cr |
| Krsnaa Diagnostics Ltd | Healthcare | 1.61% | ₹7.77 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.60% | ₹7.76 Cr |
| Krsnaa Diagnostics Ltd | Healthcare | 1.63% | ₹7.57 Cr |
| Krsnaa Diagnostics Ltd | Healthcare | 1.63% | ₹7.57 Cr |
| Orchid Pharma Ltd | Healthcare | 1.53% | ₹7.40 Cr |
| Orchid Pharma Ltd | Healthcare | 1.51% | ₹7.26 Cr |
| Orchid Pharma Ltd | Healthcare | 1.51% | ₹7.26 Cr |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | 1.49% | ₹7.17 Cr |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | 1.49% | ₹7.17 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.46% | ₹7.10 Cr |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | 1.46% | ₹7.08 Cr |
| Orchid Pharma Ltd | Healthcare | 1.51% | ₹7.02 Cr |
| Orchid Pharma Ltd | Healthcare | 1.51% | ₹7.02 Cr |
| Hikal Ltd | Healthcare | 1.40% | ₹6.79 Cr |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | 1.44% | ₹6.67 Cr |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | 1.44% | ₹6.67 Cr |
| Repo | Unspecified | 1.37% | ₹6.60 Cr |
| Repo | Unspecified | 1.37% | ₹6.60 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.33% | ₹6.38 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.33% | ₹6.38 Cr |
| Rubicon Research Ltd. | 1.32% | ₹6.37 Cr | |
| Rubicon Research Ltd. | 1.32% | ₹6.37 Cr | |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.36% | ₹6.32 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.36% | ₹6.32 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.24% | ₹6.04 Cr |
| Hikal Ltd | Healthcare | 0.70% | ₹3.27 Cr |
| Hikal Ltd | Healthcare | 0.70% | ₹3.27 Cr |
| Net Payables | Unspecified | -0.08% | ₹-0.43 Cr |
| Net Payables | Unspecified | -0.08% | ₹-0.43 Cr |
| Net Payables | Unspecified | -0.24% | ₹-1.11 Cr |
| Net Payables | Unspecified | -0.24% | ₹-1.11 Cr |
| Net Payables | Unspecified | -0.26% | ₹-1.28 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹43.71 | 28.99% | 21.62% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹40.45 | 27.87% | 20.55% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.21 | 21.53% | 15.83% | - |
Kotak Healthcare Fund Regular - Growth
What is the current AUM of Kotak Healthcare Fund Regular - Growth?
As of Thu Jul 31, 2025, Kotak Healthcare Fund Regular - Growth manages assets worth ₹485.3 crore
How has Kotak Healthcare Fund Regular - Growth performed recently?
- 3 Months: 1.22%
- 6 Months: 12.09%
What is the long-term performance of Kotak Healthcare Fund Regular - Growth?
- Since Inception: 18.33%
What is the portfolio composition of Kotak Healthcare Fund Regular - Growth?
Equity: 98.71%, Others: 1.29%.
Who manages Kotak Healthcare Fund Regular - Growth?
Kotak Healthcare Fund Regular - Growth is managed by Dhananjay Tikariha from Kotak Mahindra Mutual Fund.
What is the market-cap allocation of Kotak Healthcare Fund Regular - Growth?
Large Cap: 46.69%, Mid Cap: 16.43%, Small Cap: 36.88%.
Which are the top companies Kotak Healthcare Fund Regular - Growth has invested in?
- Sun Pharmaceutical Industries Ltd – 14.07% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 13.36% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 13.36% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 13.05% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 13.05% of the fund's portfolio
Which are the major sectors Kotak Healthcare Fund Regular - Growth focuses on?
- Healthcare – 484.55% of the fund's portfolio
- Unspecified – 12.81% of the fund's portfolio
- – 2.64% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.


